Literature DB >> 22033687

[Tumor microenvironment in gastrointestinal tumors].

B Etschmann1, S Gattenlöhner.   

Abstract

The growing potential of modern molecular analysis tools has led to a sharp increase in the understanding of the molecular dimension of pathological processes and, consequently, to a growing influence of pathological diagnoses on the selection of therapeutic approaches. Molecular analysis tools have also led to the understanding that groups of tumors hitherto considered to belong to a single, homogeneous disease entity should rather be divided into subgroups with specific molecular attributes, growth behavior patterns and, consequently, different prognostic characteristics and therapeutic needs. A major factor contributing to the differentiation of these subgroups is the composition of the tumor microenvironment (ME), a compartment that is involved in the control of critical carcinogenetic processes such as angiogenesis and invasive growth. Consequently, the investigation of the ME promises to be a most auspicious field of research for pathologists and there is hope that the increased understanding of the interaction between neoplastic cells and the ME will lead to improved diagnostic tools and novel therapeutic approaches for the treatment of cancer patients.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22033687     DOI: 10.1007/s00292-011-1530-3

Source DB:  PubMed          Journal:  Pathologe        ISSN: 0172-8113            Impact factor:   1.011


  20 in total

1.  Src-induced de-regulation of E-cadherin in colon cancer cells requires integrin signalling.

Authors:  Egle Avizienyte; Anne W Wyke; Robert J Jones; Gordon W McLean; M Andrew Westhoff; Valerie G Brunton; Margaret C Frame
Journal:  Nat Cell Biol       Date:  2002-08       Impact factor: 28.824

2.  Molecular insights into the morphology of myeloproliferative neoplasms using an in situ PCR assay specific for the JAK2 mutation V617F.

Authors:  S Gattenlohner; E Serfling; H Einsele; H K Müller-Hermelink
Journal:  Leukemia       Date:  2008-06-26       Impact factor: 11.528

3.  Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization.

Authors:  T Asahara; H Masuda; T Takahashi; C Kalka; C Pastore; M Silver; M Kearne; M Magner; J M Isner
Journal:  Circ Res       Date:  1999-08-06       Impact factor: 17.367

4.  Comparison of metabolic pathways between cancer cells and stromal cells in colorectal carcinomas: a metabolic survival role for tumor-associated stroma.

Authors:  Michael I Koukourakis; Alexandra Giatromanolaki; Adrian L Harris; Efthimios Sivridis
Journal:  Cancer Res       Date:  2006-01-15       Impact factor: 12.701

Review 5.  Heparanase: one molecule with multiple functions in cancer progression.

Authors:  Israel Vlodavsky; Michael Elkin; Ghada Abboud-Jarrous; Flonia Levi-Adam; Liat Fuks; Itay Shafat; Neta Ilan
Journal:  Connect Tissue Res       Date:  2008       Impact factor: 3.417

6.  Relationships between tumor-associated macrophages and clinicopathological factors in patients with colorectal cancer.

Authors:  Yoshifumi Nakayama; Nobuo Nagashima; Noritaka Minagawa; Yuzuru Inoue; Takefumi Katsuki; Koji Onitsuka; Tatsuhiko Sako; Keiji Hirata; Naoki Nagata; Hideaki Itoh
Journal:  Anticancer Res       Date:  2002 Nov-Dec       Impact factor: 2.480

Review 7.  The Yin-Yang of tumor-associated macrophages in neoplastic progression and immune surveillance.

Authors:  Paola Allavena; Antonio Sica; Cecilia Garlanda; Alberto Mantovani
Journal:  Immunol Rev       Date:  2008-04       Impact factor: 12.988

8.  Extracellular matrix protein betaig-h3/TGFBI promotes metastasis of colon cancer by enhancing cell extravasation.

Authors:  Chaoyu Ma; Yu Rong; Daniel R Radiloff; Michael B Datto; Barbara Centeno; Shideng Bao; Anthony Wai Ming Cheng; Fumin Lin; Shibo Jiang; Timothy J Yeatman; Xiao-Fan Wang
Journal:  Genes Dev       Date:  2008-02-01       Impact factor: 11.361

9.  Role of cancer microenvironment in metastasis: focus on colon cancer.

Authors:  Stéphanie Gout; Jacques Huot
Journal:  Cancer Microenviron       Date:  2008-03-14

Review 10.  American Society of Clinical Oncology provisional clinical opinion: testing for KRAS gene mutations in patients with metastatic colorectal carcinoma to predict response to anti-epidermal growth factor receptor monoclonal antibody therapy.

Authors:  Carmen J Allegra; J Milburn Jessup; Mark R Somerfield; Stanley R Hamilton; Elizabeth H Hammond; Daniel F Hayes; Pamela K McAllister; Roscoe F Morton; Richard L Schilsky
Journal:  J Clin Oncol       Date:  2009-02-02       Impact factor: 44.544

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.